Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
54 Cards in this Set
- Front
- Back
Km
|
affinity of enzyme for its substrate
|
|
Vmax
|
proportional to enzyme concentration
|
|
decreasing Km will do what to the affinity
|
decrease affinity
|
|
enzyme kinetics graph
1. x intercept 2. y intercept 3. slope |
1. 1/-Km
2. 1/Vmax 3. Km/Vmax |
|
EK graph
1. increasing y-intercept, does what to Vmax? 2. further right the x-intercept is, how is Km? |
1. decrease Vmax
2. greater the Km |
|
competitive vs. noncompetitive inhibitors on graph
|
competitive inhibitors cross each other
|
|
Vd=
|
amount of drug in body/plasma drug concentration
|
|
low Vd (4-8 L) distribute where?
|
in blood
|
|
medium Vd distribute where
|
extracellular space or body water
|
|
high Vd (greater than body weight) distribute where
|
in tissues
|
|
CL=
|
rate of elimination of drug/ plama drug concentration
OR Vd * Ke |
|
t1/2=
|
0.7 *Vd/ CL
|
|
competitive inhibitors
1. resemble substrate 2. overcome by increase in substrate concentration 3. bind active site 4. effect on Vmax 5. effect on Km |
1. yes
2. yes 3. yes 4. unchanged 5. increase |
|
noncompetitive inhibitors
1. resemble substrate 2. overcome by increase in substrate concentration 3. bind active site 4. effect on Vmax 5. effect on Km |
1. no
2. no 3. no 4. increase 5. unchanged |
|
calculate loading dose
|
LD= Cp x Vd/F
|
|
calculate maintenance dose
|
MD= Cp x CL/F where Cp= target plasma concentration and F= bioavailability
|
|
in patient with impaired renal and hepativ function how is loading dose
|
remains unchanged although maintenance dose is decreased
|
|
zero-order elimination
1. what is it? 2. examples of drugs? |
1. -rate of elimination is constant regardless of C (constant AMOUNT of drug eliminated per unit time)
-Cp decrease linearly with time 2. PEA (round) Phenytoin, Ethanol, Aspirin |
|
First-order elimination
1. what is it? |
1. rate of elimination is proportional to drug concentration (constant FRACTION of drug eliminated per unit time)
-Cp decrease exponentially with time |
|
Weak acids
1. Examples 2. trapped where 3. treat overdose with what? |
1. phenobarbital, methotrexate, TCas, aspirin
2. in basic environments 3. bicarbonate |
|
Weak bases
1. Examples 2. trapped where 3. treat overdose with what? |
1. amphetamines
2. in acidic environments 3. ammonium chloride |
|
Phase I metabolism
|
-cytochrome P450
-reduction, oxidation, hydrolysis -usually yields slightly polar, water-soluble metabolites |
|
Phase II metabolism
|
-conjugation
-acetylayion, glucuronidation, sulfation -usually yields very polar, inactive metabolites -renally excreted |
|
Efficacy
|
maximal effect a drug can produce
|
|
potency
|
amount of drug needed for a given effect
|
|
competitive anatagonist shifts curve how? does what?
|
to the right
-decreasing potency -increasing EC50 |
|
noncompetitve anatagonist shifts curve how? does what?
|
downward
-decreasing efficacy |
|
partial agonist acts where?
does what? how is potency? |
-acts on smae receptor system as full agonist
-lower maximal efficacy regardless of dose -is an independent factor |
|
therapeutic index is measurement of what?
|
drug safety
|
|
TI=
|
LD50/ED50 or median toxic dose/ median effective dose
TILE (TI= L/E) |
|
TI of safer drugs
|
safer drugs have higher TI values
|
|
Phase I biotransformation classification
|
-modification of drug molecule via oxidation, reduction, or hydrolysis******
-CYP450 -require for molecular oxygen and NADPH |
|
CYP450 IA2
1. substrate example 2. inducers 3. inhibitors 4. genetic polymorphism |
1. theophylline, acetaminophen
2. aromatic hydrocarbons (smoke), cruciferous veggies 3. quinolones, macrolides 4. no |
|
smoker w/ theophylline
|
-if quit smoking, need to lower dose b/c toxicity
-in current smoker, plasma levels lower so need to increase dose |
|
CYP 450 2C9
1. substrate example 2. inducers 3. inhibitors 4. genetic polymorphism |
1. phenytoin, warfarin
2. general inducers 3.-- 4. yes |
|
CYP 450 2D6
1. substrate example 2. inducers 3. inhibitors 4. genetic polymorphism |
1. many cardio and CNS drugs
2. none known 3. haloperidol, quinidine 4. yes |
|
CYP 450 3A4
1. substrate example 2. inducers 3. inhibitors 4. genetic polymorphism |
1. 60% of drugs in PDR
2. general inducers 3. general inhibitors, grapefruit juice 4. no |
|
grape fruit juice
|
-high cholesterol and on statin and drink GF juice-- increase risk of statin toxicity
-active component- furanocoumarins -Ex. alprazolam, midazolam, atorvastin*****, and cyclosporine |
|
cimetidine
|
-for ulcers
-inhibit metabolism of drug and plasma level increase |
|
general inducers
|
Smoking PCP on a RAG
-smoking -PCP -rifampin -anticonvulsants (barbs, phenytoin, carbamazepine) -glucocorticoids, -alcohol ---stimulate liver to make more enzymes -lowers plasma level of substrate and makes less effective |
|
general inhibitors
|
-Grapefuit juice and COKE with your PIe
-pi= protease inhibitor- ritovir -cimetidine, omeprazole, ketoconazole -chloramphenical -macrolides -acute alcohol -raises plasma level of substrate and make more effective |
|
pt. given on theophylline and has chronic broncitis is given macrolides
|
-want to bronchodilate
-macrolides- for resp. infection -increase plasma level of theophylline -increase risk of toxicity |
|
what is elimination
|
termination of drug action
|
|
2 major ways to get rid of drugs
|
biotransformation
-excretion |
|
zero-order elimination rate
|
-constant AMOUNT of drug is eliminated per unit of time
-no half-life -rate of elimination is indepent of plasma concentration = high dose (saturation, working at max capacity) |
|
3 drugs with zero-order elimination
|
1. ethanol
2. phentoin 3. aspirin -at high doese |
|
zero-order graphs
1. x- time and y-units of drug 2. x- time and y-log units of drug |
1. down linear
2. upside-down- U but decreasing |
|
first-order elimination
|
-constant fraction of drug is eliminated per unit time
-half-life applies |
|
Phase II biotransformation
|
-conjugation with endogenous compounds via activity of TRANSFERASES
-conjugation--glucoronidation, acetylation, glutathione conjugation |
|
Glucoronosyl transferase*****
|
-involved in glucoronidation
|
|
acetylation
|
phase II
-drug induced SLE by slow acetylators-- (hydralazine*****> procainamine> isoniazid "It's HIP to have lupus" |
|
-CV: chloramphenicol toxicity
|
-Grey-Baby syndrome
-mech of toxicity- b/c neonates have lower lvels of GT and can't metabolize |
|
CV: GT deficiency
|
Gilbert or Crigler-Najjar
-can't conjugate bilirubin -get jaundice |
|
CV: butterfly malar rash; +ANA
|
-antihistones antibodies= drug-induced
-stop drug and SLE goes away |